Robert Berman, Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 45,667 shares at $25.55 ($1.2M) on 2017-11-13, disclosed to the SEC on 2017-11-14.
Open-market sale of $1.2M BHVN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.55 | 8,398 | $215K | 18.4% |
| 2 | $25.55 | 33,589 | $858K | 73.4% |
| 3 | $26.22 | 3,680 | $96K | 8.3% |
| Total | $25.60 avg | 45,667 | $1.2M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-22 | $9.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $13.3M | — | Filing → |
| BHVN | SELL | 2019-12-31 | $6.6M | — | Filing → |